| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.8M | — | +1.5% |
| Cost of Revenue | $4.2M | — | -1.3% |
| Gross Profit | $1.7M | — | +9.2% |
| R&D Expense | $38K | — | -10.5% |
| SG&A Expense | $913K | — | +3.2% |
| Operating Income | -$15K | — | +87.7% |
| Pre-tax Income | -$131K | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $1.6M | -3.0% | +29.5% |
| Inventory | $3.8M | +6.1% | +26.7% |
| Current Assets | $6.3M | +4.6% | +15.9% |
| Total Assets | $8.8M | +0.7% | +0.1% |
| Current Liabilities | $5.3M | +5.5% | +16.1% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $80K | — | -39.4% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $0 | — | +100.0% |
| Financing Cash Flow | $3K | — | +103.3% |
| Free Cash Flow | $80K | — | -38.9% |
| +37.6% |
| Income Tax | $0 | — | — |
| Net Income | -$131K | — | +37.6% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| $722K |
| +2.8% |
| +35.2% |
| Total Liabilities | $6.5M | +2.8% | +5.5% |
| Stockholders' Equity | $2.3M | -5.0% | -12.6% |